EMGE.US Emergent Health Corp
- Market cap
- USD 42.7K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2024.
Is EMGE.US undervalued?
Graham numberThe Graham number of Emergent Health Corp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Emergent Health Corp fundamental analysis
No fundamental analysis for Emergent Health Corp yet.
Emergent Health Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Emergent Health Corp
Emergent Health Corp. manufactures and sells vitamin products to retail customers across the United States of America. Emergent Health Corp. was incorporated in 2006 and is based in North Bergen, New Jersey.
Full company profileEmergent Health Corp financial statements
2024 annualized: Fiscal year 2024 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2024, the balance sheet is the latest quarter. Figures change when the annual report is published.
Emergent Health Corp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2010 | 2011 | 2012 | 2013 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 240K | 707K | 1.37K | 990K | 183K | 167K | 120K | 575K | 1.64M | - |
| Gross Profit | 46.1K | 250K | 802.30 | 729K | 129K | 121K | 59.5K | 128K | 1.04M | - |
| Operating Income | 46.1K | 250K | 225.47 | 189K | -58.7K | -79.7K | -200K | -1.76M | -1.41M | -272K |
| EBITDA | - | - | 225.82 | 190K | -48.7K | -56.0K | -180K | -1.73M | -1.39M | -259K |
| Net Income | 48.3K | 253K | 131.64 | 121K | -67.5K | -79.1K | -289K | -2.11M | -1.63M | -517K |
| EPS | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| Balance Sheet | ||||||||||
| Total Assets | 422K | 1.06M | 905.71 | 1.03M | 404K | 321K | 379K | 790K | 534K | 209K |
| Total Liabilities | 17.9K | 313K | 69.46 | 75.2K | 3.75K | - | 347K | 1.85M | 2.89M | 3.37M |
| Shareholders' Equity | 404K | 744K | 836.25 | 957K | 311K | 233K | -55.6K | -1.14M | -2.44M | -3.24M |
| Cash & Short-term Investments | 0.00 | 0.00 | 737.30 | 814K | 227K | 169K | 258K | 348K | 359K | 2.11K |
| Total Debt | - | - | - | - | - | - | 338K | 1.66M | 2.48M | 2.66M |
| Cash Flow | ||||||||||
| Operating Cash Flow | -29.3K | -29.3K | -29.26 | 77.0K | -54.2K | -57.3K | -162K | -1.90M | -1.22M | -265K |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 50.0K | 2.00 | 5.33 |
| Free Cash Flow | - | - | -29.26 | 77.0K | -54.2K | -57.3K | -162K | -1.95M | -1.22M | -265K |
| Ratios | ||||||||||
| ROE | 11.9% | 34.1% | 15.7% | 12.6% | -21.7% | -33.9% | - | - | - | - |
| ROA | 11.4% | 24.0% | 14.5% | 11.7% | -16.7% | -24.6% | -76.2% | -266.7% | -305.1% | -247.1% |
| Net Profit Margin | 20.1% | 35.9% | 9.6% | 12.2% | -36.9% | -47.3% | -241.5% | -366.8% | -99.6% | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Emergent Health Corp dividends
Emergent Health Corp has not paid dividends in the last 9 fiscal years.
Last stock split: 11:10 on Dec 31, 2009.
Who owns Emergent Health Corp
Ownership data of Emergent Health Corp is not available yet.
Emergent Health Corp company profile
- Company name
- Emergent Health Corp
- Ticker
- EMGE.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Fiscal year end
- December
- Address
- One Marine Plaza, North Bergen, NJ, United States, 04047
- Phone
- 786-369-9696
- Website
- emergenthealthcompany.com
About Emergent Health Corp
Emergent Health Corp. manufactures and sells vitamin products to retail customers across the United States of America. Emergent Health Corp. was incorporated in 2006 and is based in North Bergen, New Jersey.
Emergent Health Corp management
3- Mr. James W. ZimblerChief Executive Officer · born 1961
- Mr. Gregory McCauleyCorporate Counsel
- Mr. Marvin SegelDirector & CMO